Annual Report & Notice of AGM

Assura PLC
31 May 2024
 

31 May 2024

Assura plc

Annual Report & Notice of AGM

Assura plc ("Assura"), the specialist healthcare property investor and developer, is pleased to announce that the Annual General Meeting ("AGM") will be held on Thursday 4 July 2024 at 11am BST.

The Annual Report and Accounts for the year ended 31 March 2024 and the Notice of AGM will be posted to shareholders today. 

In accordance with Listing Rule 9.6.1, copies of these documents have also been submitted to the UK Listing Authority via the National Storage Mechanism and will be available for viewing shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and can also be found on the Company's website at http://assuraplc.com/investor-relations/reports-and-presentations/.

Shareholders will be able to watch the AGM over the online Investor Meet Company platform by registering in advance via the following link:

https://www.investormeetcompany.com/assura-plc/register-investor

Shareholders are invited to submit any questions in respect of the business of the AGM for the Board to consider. Questions may be submitted in advance over the Investor Meet Company platform following registration and the Board will aim to respond to any such questions relevant to the business of the AGM. Further information is set out in the Notice of AGM.

Shareholders wishing to vote at the AGM are strongly encouraged to do so by completing a Form of Proxy as appropriate. Shareholders will not be able to vote at the meeting over the online platform.

- Ends -

 

For more information, please contact:

Assura plc
David Purcell, Investor Relations Director

Tel: 0161 515 2043
Email: Investor@assura.co.uk

Finsbury Glover Hering

Gordon Simpson

Tel: 0207 251 3801
Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Assura (AGR)
UK 100

Latest directors dealings